Showing 1 - 8 results of 8 for search 'Bryon D Johnson', query time: 0.05s Refine Results
  1. 1
    PD-1 blockade after bispecific LV20.19 CAR T modulates CAR T-cell immunophenotype without meaningful clinical response

    PD-1 blockade after bispecific LV20.19 CAR T modulates CAR T-cell immunophenotype without meaningful clinical response by Joanna Zurko, Katherine Chaney, John M. Astle, Bryon D. Johnson, Parameswaran Hari, Nirav N. Shah

    Published 2021-04-01
    Get full text
    Article
  2. 2
    Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice

    Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice by Weiqing Jing, Juan Chen, Yuanhua Cai, Yingyu Chen, Jocelyn A. Schroeder, Bryon D. Johnson, Weiguo Cui, Qizhen Shi

    Published 2019-10-01
    Get full text
    Article
  3. 3
    Adoptive cell therapy using PD-1+ myeloma-reactive T cells eliminates established myeloma in mice

    Adoptive cell therapy using PD-1+ myeloma-reactive T cells eliminates established myeloma in mice by Weiqing Jing, Jill A. Gershan, Grace C. Blitzer, Katie Palen, James Weber, Laura McOlash, Matthew Riese, Bryon D. Johnson

    Published 2017-06-01
    Get full text
    Article
  4. 4
    Prevention of Tumor Growth and Dissemination by In Situ Vaccination with Mitochondria‐Targeted Atovaquone

    Prevention of Tumor Growth and Dissemination by In Situ Vaccination with Mitochondria‐Targeted Atovaquone by Mofei Huang, Donghai Xiong, Jing Pan, Qi Zhang, Yian Wang, Charles R. Myers, Bryon D. Johnson, Micael Hardy, Balaraman Kalyanaraman, Ming You

    Published 2022-04-01
    Get full text
    Article
  5. 5
    The effect of tocilizumab on patient reported outcomes and inflammatory biomarkers in hematopoietic cell transplantation

    The effect of tocilizumab on patient reported outcomes and inflammatory biomarkers in hematopoietic cell transplantation by Mallory R. Taylor, Cecilia J. Hillard, William R. Drobyski, Aniko Szabo, Bryon D. Johnson, Fenlu Zhu, Charles L. Raison, Steve W. Cole, Jennifer M. Knight

    Published 2022-08-01
    Get full text
    Article
  6. 6
    382 TIM-3 blockade combined with adoptive therapy of ex vivo activated NK cells after allogeneic hematopoietic stem cell transplant reduces progression of relapsed murine neuroblastoma

    382 TIM-3 blockade combined with adoptive therapy of ex vivo activated NK cells after allogeneic hematopoietic stem cell transplant reduces progression of relapsed murine neuroblas... by Christian Capitini, Nicholas J Hess, Aicha Quamine, Nicholas R Mohrdieck, Chloe A King, Anastasia A Griggs, Katharine E Tippins, Paul D Bates, Tyce J Kearl, Bryon D Johnson

    Published 2023-11-01
    Article
  7. 7
    Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression

    Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression by Mahmoud AbuEid, Donna M. McAllister, Laura McOlash, Megan Cleland Harwig, Gang Cheng, Donovan Drouillard, Kathleen A. Boyle, Micael Hardy, Jacek Zielonka, Bryon D. Johnson, R. Blake Hill, Balaraman Kalyanaraman, Michael B. Dwinell

    Published 2021-06-01
    Get full text
    Article
  8. 8
    Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA

    Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA by Jing Pan, Yao Chen, Qi Zhang, Achia Khatun, Katie Palen, Gang Xin, Li Wang, Chuanjia Yang, Bryon D. Johnson, Charles R. Myers, Shizuko Sei, Robert H. Shoemaker, Ronald A. Lubet, Yian Wang, Weiguo Cui, Ming You

    Published 2021-07-01
    Get full text
    Article

Search Tools: